Annual Total Expenses
$181.59 M
+$27.94 M+18.18%
December 31, 2024
Summary
- As of March 12, 2025, PTGX annual total expenses is $181.59 million, with the most recent change of +$27.94 million (+18.18%) on December 31, 2024.
- During the last 3 years, PTGX annual total expenses has risen by +$28.39 million (+18.53%).
- PTGX annual total expenses is now at all-time high.
Performance
PTGX Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$43.86 M
-$2.27 M-4.92%
December 31, 2024
Summary
- As of March 12, 2025, PTGX quarterly total expenses is $43.86 million, with the most recent change of -$2.27 million (-4.92%) on December 31, 2024.
- Over the past year, PTGX quarterly total expenses has dropped by -$2.27 million (-4.92%).
- PTGX quarterly total expenses is now -9.84% below its all-time high of $48.64 million, reached on March 31, 2024.
Performance
PTGX Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
PTGX Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +18.2% | -4.9% |
| 3 y3 years | +18.5% | -4.9% |
| 5 y5 years | +124.9% | -4.9% |
PTGX Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +18.5% | -9.8% | +35.8% |
| 5 y | 5-year | at high | +124.9% | -9.8% | +119.1% |
| alltime | all time | at high | +1848.6% | -9.8% | +1531.0% |
Protagonist Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $181.59 M(+18.2%) | $43.86 M(-4.9%) |
| Sep 2024 | - | $46.13 M(+7.4%) |
| Jun 2024 | - | $42.96 M(-11.7%) |
| Mar 2024 | - | $48.64 M(+31.6%) |
| Dec 2023 | $153.65 M(-2.7%) | $36.95 M(-3.6%) |
| Sep 2023 | - | $38.33 M(-9.5%) |
| Jun 2023 | - | $42.35 M(+17.6%) |
| Mar 2023 | - | $36.02 M(-1.4%) |
| Dec 2022 | $157.95 M(+3.1%) | $36.52 M(+13.0%) |
| Sep 2022 | - | $32.30 M(-23.6%) |
| Jun 2022 | - | $42.30 M(-9.7%) |
| Mar 2022 | - | $46.83 M(+2.6%) |
| Dec 2021 | $153.20 M(+64.5%) | $45.63 M(+3.2%) |
| Sep 2021 | - | $44.21 M(+33.4%) |
| Jun 2021 | - | $33.15 M(+9.7%) |
| Mar 2021 | - | $30.21 M(+23.4%) |
| Dec 2020 | $93.14 M(+15.3%) | $24.48 M(+17.2%) |
| Sep 2020 | - | $20.89 M(-14.5%) |
| Jun 2020 | - | $24.43 M(+4.7%) |
| Mar 2020 | - | $23.34 M(+16.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $80.75 M(+10.3%) | $20.02 M(-6.1%) |
| Sep 2019 | - | $21.31 M(-8.2%) |
| Jun 2019 | - | $23.22 M(+43.3%) |
| Mar 2019 | - | $16.21 M(-8.8%) |
| Dec 2018 | $73.19 M(+26.3%) | $17.77 M(+14.6%) |
| Sep 2018 | - | $15.51 M(-25.9%) |
| Jun 2018 | - | $20.91 M(+10.0%) |
| Mar 2018 | - | $19.01 M(+28.5%) |
| Dec 2017 | $57.96 M(+77.4%) | $14.79 M(+7.5%) |
| Sep 2017 | - | $13.76 M(-9.1%) |
| Jun 2017 | - | $15.13 M(+6.0%) |
| Mar 2017 | - | $14.27 M(+25.2%) |
| Dec 2016 | $32.67 M(+120.8%) | $11.40 M(+59.7%) |
| Sep 2016 | - | $7.14 M(+0.7%) |
| Jun 2016 | - | $7.09 M(+0.7%) |
| Mar 2016 | - | $7.04 M(+40.8%) |
| Dec 2015 | $14.79 M(+58.8%) | $5.00 M(+24.4%) |
| Sep 2015 | - | $4.02 M(+30.4%) |
| Jun 2015 | - | $3.08 M(+14.7%) |
| Mar 2015 | - | $2.69 M |
| Dec 2014 | $9.32 M | - |
FAQ
- What is Protagonist Therapeutics annual total expenses?
- What is the all time high annual total expenses for Protagonist Therapeutics?
- What is Protagonist Therapeutics annual total expenses year-on-year change?
- What is Protagonist Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly total expenses year-on-year change?
What is Protagonist Therapeutics annual total expenses?
The current annual total expenses of PTGX is $181.59 M
What is the all time high annual total expenses for Protagonist Therapeutics?
Protagonist Therapeutics all-time high annual total expenses is $181.59 M
What is Protagonist Therapeutics annual total expenses year-on-year change?
Over the past year, PTGX annual total expenses has changed by +$27.94 M (+18.18%)
What is Protagonist Therapeutics quarterly total expenses?
The current quarterly total expenses of PTGX is $43.86 M
What is the all time high quarterly total expenses for Protagonist Therapeutics?
Protagonist Therapeutics all-time high quarterly total expenses is $48.64 M
What is Protagonist Therapeutics quarterly total expenses year-on-year change?
Over the past year, PTGX quarterly total expenses has changed by -$2.27 M (-4.92%)